Ethics and Governance of Biomedical Research (eBook)

Introducing new domains of research governance; Govind C. Persad, JD,
BS, BA.- Should Research Ethics Encourage the Production of Cost-Effect Interventions?; Rebecca Johnson, MA.-  From altruists to Workers: What
Claims Should Healthy Participants in Phase I Trials Have Against Trial
Employers?; Luana Colloca, PhD.- Nocebo effect: The dilemma of disclosing
adverse events; Jan-Ole Reichardt, MA.- Encouraging conscientiousness in risk associated areas of medical
research Challenges in common domains of research governance; Sara Anna Suzan
Dekking, MAE et al.- Discriminating between Research and Care in Paediatric
Oncology. Ethical Appraisal of the ALL- 10 and 11 protocols of the Dutch
Childhood Oncology Group (DCOG); Imme Petersen, PhD et al.- What Does the
Child’s Assent to Research Participation Mean to Parents? Empirical Findings in
Paediatric Oncology in Germany; Marcin Waligóra, PhD.- Assent in paediatric
research and its consequences; Rosemarie Bernabe, PhD.- Ethical Issues in
Postauthorization Drug Trials; Anette Blümle, PhD et al.- Fate of Clinical
Research Studies after Ethical Approval – Follow-Up of Study Protocols until
Publication; Daniel Strech, MD, PhD.- et al. Do editorial policies support
ethical research? A thematic text analysis of author instructions in psychiatry
journals Improving common domains of research governance; Jonathan
Kimmelman, PhD.- Risk/Benefit Assessment in Launching Early Human
Trials; Annette Rid, MD.- Guidelines for Biomedical Research Involving Human Subjects
Setting Thresholds of Acceptable Research Risk: Lessons from the Debate about
Minimal Risk; Sapfo Lignou, MSc, MA et al.- Towards an Alternative Account for
Defining Acceptable Risk in Non-beneficial Pediatric Research; Roger
Brownsword, PhD.- Big biobanks: Three Major Governance Challenges and Some
Mini-Constitutional Responses; Bettina Schmietow, MA.- Dynamic Consent to
Biobank Research – Paradigm Shift or Red Herring?.